Hypha Discovery is a microbial technology company helping partners in pharmaceutical and agrochemical R&D succeed through the discovery and production of microbial and mammalian metabolites. We are experts in the scalable production of DMPK metabolites and generation of polar analogues, and are also a leading provider of unique natural product screening libraries and associated services.
NEWS & EVENTS
3rd New Perspectives in DMPK: the impact of drug design, 8th-9th February 2016, Royal Society of Chemistry at Burlington House, London
The BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry, 9th March, 3M Buckley Innovation Centre, University of Huddersfield
Our metabolite production platform now includes a parent-to-product “one step synthesis” service. By coupling this development with state-of-the-art NMR technology, we are now able to offer a definitive Met ID service, for which only low μg amounts are required to provide unambiguous structural identification.